What Aditya Birla Sun Life Nifty Healthcare ETF bought and sold in September 2026
This compares the fund's portfolio at the end of September 2026 with the month before. Both come from the monthly portfolio statement of Aditya Birla Sun Life Mutual Fund.
Aditya Birla Sun Life Nifty Healthcare ETF Stocks Bought and Sold
All changes are between August 2026 and September 2026
More
| Sun Pharmaceutical Industries Ltd. | Reduced | −8.0% | 17.00% |
|---|---|---|---|
| Divi's Laboratories Ltd. | Reduced | −7.8% | 10.46% |
| Apollo Hospitals Enterprise Ltd. | Reduced | −7.7% | 7.45% |
| Cipla Ltd. | Reduced | −8.0% | 6.69% |
| Laurus Labs Ltd. | Reduced | −8.0% | 6.81% |
| Max Healthcare Institute Ltd. | Reduced | −8.1% | 6.11% |
| Dr. Reddy's Laboratories Ltd. | Reduced | −8.0% | 6.64% |
| Torrent Pharmaceuticals Ltd. | Reduced | −7.4% | 6.26% |
| Lupin Ltd. | Reduced | −8.2% | 4.35% |
| Aurobindo Pharma Ltd. | Reduced | −8.2% | 4.08% |
| Fortis Healthcare Ltd. | Reduced | −8.1% | 3.54% |
| Glenmark Pharmaceuticals Ltd. | Reduced | −8.3% | 3.10% |
| Alkem Laboratories Ltd. | Reduced | −4.5% | 2.77% |
| Zydus Lifesciences Ltd. | Reduced | −9.1% | 2.54% |
| Biocon Ltd. | Reduced | −10.2% | 2.28% |
| Mankind Pharma Ltd. | Reduced | −8.3% | 2.50% |
| IPCA Laboratories Ltd. | Reduced | −8.2% | 2.36% |
| Gland Pharma Ltd. | New | New | 2.04% |
| Krishna Institute of Medical Sciences Ltd. | New | New | 1.76% |
| Abbott India Ltd. | Reduced | −9.7% | 1.22% |
| Piramal Pharma Ltd. | Sold out | −100% | was 1.15% |
| Syngene International Ltd. | Sold out | −100% | was 0.66% |
No stocks in this group for September 2026.
A change is counted by the number of shares the fund holds, not by price. A stock can become a smaller part of the fund in a month when the fund bought more of it, if its price fell. Debt papers are left out.
Frequently Asked Questions
Which new stocks did Aditya Birla Sun Life Nifty Healthcare ETF buy in September 2026?
It bought 2 new stocks: Gland Pharma Ltd (2.04%) and Krishna Institute of Medical Sciences Ltd (1.76%). Each figure is the stock's share of the fund at the end of September 2026.
Which stocks did Aditya Birla Sun Life Nifty Healthcare ETF sell completely in September 2026?
It sold all its shares in Piramal Pharma Ltd (1.15%) and Syngene International Ltd (0.66%). Each figure is the stock's share of the fund at the end of August 2026.
Which stocks did Aditya Birla Sun Life Nifty Healthcare ETF sell part of in September 2026?
The largest cuts in shares held were Biocon Ltd (−10.2%), Abbott India Ltd (−9.7%), Zydus Lifesciences Ltd (−9.1%), Mankind Pharma Ltd (−8.3%) and Glenmark Pharmaceuticals Ltd (−8.3%). It reduced 13 more.
How are these changes worked out?
WealthGamma compares the number of shares Aditya Birla Sun Life Nifty Healthcare ETF held on 30-09-2026 with 31-08-2026. Both figures come from the monthly portfolio statement of Aditya Birla Sun Life Mutual Fund. A change in share price alone does not count as buying or selling.
See NAV, expense ratio and full holdings of Aditya Birla Sun Life Nifty Healthcare ETF
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.